GE to supply sequencing technology for breast cancer research

09/29/2013 | Genetic Engineering & Biotechnology News

Researchers at Karolinska Institutet in Europe will use GE Healthcare's sequencing technology to detect alleles and mutations linked to metastatic breast cancer. The deal, whose terms were not disclosed, is part of GE's initiative to invest in the development of novel molecular imaging and cancer diagnostic capabilities. The company is also investing in biopharmaceutical manufacturing.

View Full Article in:

Genetic Engineering & Biotechnology News

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director of Behavioral Health Operations
Meridian Health Plan
Detroit, MI
Medical Director
PacificSource
Bend, OR
Clinical Appeals RN
MJHS
Brooklyn, NY
Director of Clinical Operations
Meridian Health Plan
Detroit, MI
Sr. Director, Regulatory Compliance Intelligence and Outreach
Johnson & Johnson
New Brunswick, NJ